NCT00775281
- Conditions
- Chronic Pelvic Pain Syndrome, Cystitis, Cystitis, Interstitial, +13 more
- Locations
-
- Dept. of Urology, Bern University Hospital Bern, Switzerland
Clinical trial condition
Urinary Bladder, Overactive
Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.
599 public trials
57 recruiting studies
Urinary Bladder, Overactive trial results
NCT00746681
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Hradec Králové, Czechia
- Pfizer Investigational Site Prague, Czechia
- Pfizer Investigational Site Prague, Czechia
- Pfizer Investigational Site Praha 4 - Krc, Czechia
NCT01003457
- Conditions
- Detrusor Overactivity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Insubria Varese, varese, Italy
Completed
516-BOTOX Urinary Incontinence Detrusor
NCT00850733
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
- Locations
-
Not specified
Completed
Fesoterodine Flexible Dose Study
NCT00536484
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Chandler, Arizona, United States
- Pfizer Investigational Site Peoria, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
NCT00742833
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
- Locations
-
- Japan Hokkaido Region, Japan
- Japan Kansai Region, Japan
- Japan Kanto Region, Japan
- Japan Kyushu Region, Japan
NCT00883818
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +15 more
- Locations
-
- Inha University College of Medicine Inchon, South Korea
- Kangnam St. Mary's Hospital, The Catholic University of Korea Seoul, South Korea
- Asan Medical Center, Ulsan College of Medicine Seoul, South Korea
Completed
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
NCT00343486
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- GSK Investigational Site Av Córdoba 2424, Buenos Aires, Argentina
- GSK Investigational Site Bahía Blanca, Buenos Aires, Argentina
- GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina
NCT00903045
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00814736
- Conditions
- Erectile Dysfunction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
- Locations
-
- Pfizer Investigational Site Singapore